CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived

Rainer Gosert1, Christine Hanssen Rinaldo, Marion Wernli

  • 1Transplantation Virology, Institute for Medical Microbiology, Department of Biomedicine, University of Basel, and Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Petersplatz 10, CH-4003 Basel, Switzerland.

Insights

CMX001 effectively inhibits JC virus (JCV) replication in human brain cells, offering a potential treatment for progressive multifocal leukoencephalopathy (PML). This antiviral shows promise for patients with compromised immune systems.

Area of Science:

  • Virology
  • Neuroscience
  • Pharmacology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a fatal brain disease caused by JC virus (JCV) replication.
  • Immunodeficient patients are particularly susceptible to PML, and effective antiviral treatments are currently lacking.

Purpose of the Study:

  • To characterize the antiviral activity of CMX001 against JCV replication in human brain progenitor-derived astrocytes (PDA) and COS-7 cells.
  • To evaluate the efficacy and toxicity of CMX001 in vitro.

Main Methods:

  • JCV replication was assessed using PCR and immunofluorescence assays.
  • Host cell toxicity was determined by WST-1 and BrdU incorporation assays.
  • Antiviral efficacy was quantified by calculating EC50, CC50, and SI50 values.

Main Results:

  • CMX001 demonstrated a dose-dependent reduction in JCV loads and infectivity in PDA.
  • CMX001 exhibited potent antiviral activity with low toxicity in PDA (SI50 = 33.3, SI90 = 256.1).
  • JCV replication was inhibited by CMX001 at concentrations achievable through oral administration.

Conclusions:

  • CMX001 is a potent inhibitor of JCV replication in vitro.
  • CMX001 shows a favorable selectivity index, suggesting therapeutic potential for PML treatment.
  • Further clinical studies are warranted to evaluate CMX001's efficacy and safety in patients.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...